Terms: = Germ cell tumor AND PSA
166 results:
1. Multivariate Mendelian randomization provides no evidence for causal associations among both psoriasis and psoriatic arthritis, and skin cancer.
Yu N; Wang J; Liu Y; Guo Y
Front Immunol; 2023; 14():1252720. PubMed ID: 37795084
[TBL] [Abstract] [Full Text] [Related]
2. Clinical, pathologic, and molecular features of amphicrine prostate cancer.
Graham LS; Haffner MC; Sayar E; Gawne A; Schweizer MT; Pritchard CC; Coleman I; Nelson PS; Yu EY
Prostate; 2023 May; 83(7):641-648. PubMed ID: 36779357
[TBL] [Abstract] [Full Text] [Related]
3. Addressing the need for more therapeutic options in neuroendocrine prostate cancer.
Kemble J; Kwon ED; Karnes RJ
Expert Rev Anticancer Ther; 2023 Feb; 23(2):177-185. PubMed ID: 36698089
[TBL] [Abstract] [Full Text] [Related]
4. Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma With BRAF Mutation From a US Payer Perspective.
Halloush S; Alkhatib NS; Almutairi AR; Calamia M; Halawah H; Obeng-Kusi M; Hoyle M; Rashdan O; Koeller J; Abraham I
Ann Pharmacother; 2023 Sep; 57(9):1016-1024. PubMed ID: 36639851
[TBL] [Abstract] [Full Text] [Related]
5. Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study.
Egger S; Smith DP; Patel MI; Kimlin MG; Armstrong BK; Nair-Shalliker V
Br J Cancer; 2023 Jan; 128(1):71-79. PubMed ID: 36319848
[TBL] [Abstract] [Full Text] [Related]
6. Polysialic Acid Sustains the Hypoxia-Induced Migration and Undifferentiated State of Human Glioblastoma cells.
Rosa P; Scibetta S; Pepe G; Mangino G; Capocci L; Moons SJ; Boltje TJ; Fazi F; Petrozza V; Di Pardo A; Maglione V; Calogero A
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076963
[TBL] [Abstract] [Full Text] [Related]
7. A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer.
Brown LC; Halabi S; Somarelli JA; Humeniuk M; Wu Y; Oyekunle T; Howard L; Huang J; Anand M; Davies C; Patel P; Staats J; Weinhold KJ; Harrison MR; Zhang T; George DJ; Armstrong AJ
Prostate Cancer Prostatic Dis; 2022 Apr; 25(4):762-769. PubMed ID: 35292724
[TBL] [Abstract] [Full Text] [Related]
8. Prostatic Schwannoma Presenting with Prostate-specific Antigen Elevation: A Case Report.
Lai BCH; Shih HJ; Syu SH; Lin KH
Yale J Biol Med; 2021 Dec; 94(4):609-612. PubMed ID: 34970099
[No Abstract] [Full Text] [Related]
9. Neuroendocrine Carcinoma as an Independent Prognostic Factor for Patients With Prostate Cancer: A Population-Based Study.
Yao J; Liu Y; Liang X; Shao J; Zhang Y; Yang J; Zheng M
Front Endocrinol (Lausanne); 2021; 12():778758. PubMed ID: 34956090
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological and genetic analyses of small cell neuroendocrine carcinoma of the prostate: Histological features for accurate diagnosis and toward future novel therapies.
Ida A; Okubo Y; Kasajima R; Washimi K; Sato S; Yoshioka E; Osaka K; Suzuki T; Yamamoto Y; Yokose T; Kishida T; Miyagi Y
Pathol Res Pract; 2022 Jan; 229():153731. PubMed ID: 34952423
[TBL] [Abstract] [Full Text] [Related]
11. [Diagnosis and treatment of small cell neuroendocrine carcinoma of the prostate].
Zhang M; Shi W; Zhang QW; Wang W; Li QY
Zhonghua Nan Ke Xue; 2021 Mar; 27(3):219-225. PubMed ID: 34914303
[TBL] [Abstract] [Full Text] [Related]
12. Route of intracellular uptake and cytotoxicity of sesamol, sesamin, and sesamolin in human melanoma SK-MEL-2 cells.
Srisongkram T; Weerapreeyakul N
Biomed Pharmacother; 2022 Feb; 146():112528. PubMed ID: 34906777
[TBL] [Abstract] [Full Text] [Related]
13. Prostatic tissue: an unexpected finding in a mature ovarian teratoma : Case report and systematic literature review.
Pecorella I; Framarino Dei Malatesta ML; Riganelli L; Ciardi G; Porpora MG
Arch Gynecol Obstet; 2022 Apr; 305(4):969-976. PubMed ID: 34618214
[TBL] [Abstract] [Full Text] [Related]
14. PAQR6 Upregulation Is Associated with AR Signaling and Unfavorite Prognosis in Prostate Cancers.
Yang M; Li JC; Tao C; Wu S; Liu B; Shu Q; Li B; Zhu R
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572596
[TBL] [Abstract] [Full Text] [Related]
15. Association of intraductal carcinoma of the prostate detected by initial histological specimen and neuroendocrine prostate cancer: A report of three cases.
Ikeda J; Ohe C; Ohsugi H; Matsuda T; Tsuta K; Kinoshita H
Pathol Int; 2021 Sep; 71(9):621-626. PubMed ID: 34297443
[TBL] [Abstract] [Full Text] [Related]
16. Somatic-Type Yolk Sac tumor Arising as a Predominant Component of Bladder Urothelial Carcinoma.
Collins K; Alkashash AM; Hwang M; Kaimakliotis HZ; Cheng L; Idrees MT
Int J Surg Pathol; 2022 Apr; 30(2):207-213. PubMed ID: 34255554
[TBL] [Abstract] [Full Text] [Related]
17. Smoothened loss is a characteristic of neuroendocrine prostate cancer.
Wang L; Li H; Li Z; Li M; Tang Q; Wu C; Lu Z
Prostate; 2021 Jun; 81(9):508-520. PubMed ID: 33955576
[TBL] [Abstract] [Full Text] [Related]
18. Clinicopathologic features of metastatic small cell carcinoma of the prostate to the liver: a series of four cases.
Bell PD; Huber AR; Agostini-Vulaj D
Diagn Pathol; 2021 Apr; 16(1):35. PubMed ID: 33892760
[TBL] [Abstract] [Full Text] [Related]
19. Prostate cancer testicular metastasis: Are they underestimated? Case report and analysis of the literature.
Smelzo S; Mantica G; Lucianò R; Tenace NP; De Marchi D; Pini G; Passaretti G; Losa A; Gaboardi F
Urologia; 2022 Nov; 89(4):645-647. PubMed ID: 33832367
[TBL] [Abstract] [Full Text] [Related]
20. Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands.
Hagendijk ME; van der Schans S; Boersma C; Postma MJ; van der Pol S
Eur J Health Econ; 2021 Aug; 22(6):991-999. PubMed ID: 33829344
[TBL] [Abstract] [Full Text] [Related]
[Next]
